BE demonstrated in pilot study [Power / Sample Size]

posted by H_Rotter – Germany, 2006-05-20 15:56 (6935 d 15:34 ago) – Posting: # 132
Views: 19,053

Hi Joy,

at least for the USA it should be possible to show BE in a pilot study, because http://www.fda.gov/cder/guidance/5356fnl.pdf FDA states at
III.A.2. Pilot study:
“[…] A pilot study that documents BE can be appropriate, provided its design and execution are suitable and a sufficient number of subjects (e.g., 12) have completed the study.”

But don’t ask me, what ‘sufficient number’ actually means. :confused:

Best regards,
Hermann


Edit: Link corrected to latest archived copy. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
206 visitors (0 registered, 206 guests [including 7 identified bots]).
Forum time: 07:31 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5